These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33642313)

  • 41. [Congenital myasthenic syndrome with COLQ gene mutation: report of a case].
    Ren HQ; Zhang JW; Wang LY; Xue P; An HB
    Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):269-271. PubMed ID: 32187901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Molecular bases and therapeutic strategies in defective neuromuscular transmissions: lessons learned from a prototypical synapse].
    Ohno K; Ito M; Masuda A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Aug; 29(4):145-51. PubMed ID: 19764481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Congenital myasthenic syndrome in Golden Retrievers is associated with a novel COLQ mutation.
    Tsai KL; Vernau KM; Winger K; Zwueste DM; Sturges BK; Knipe M; Williams DC; Anderson KJ; Evans JM; Guo LT; Clark LA; Shelton GD
    J Vet Intern Med; 2020 Jan; 34(1):258-265. PubMed ID: 31769119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.
    Durmus H; Shen XM; Serdaroglu-Oflazer P; Kara B; Parman-Gulsen Y; Ozdemir C; Brengman J; Deymeer F; Engel AG
    Neuromuscul Disord; 2018 Apr; 28(4):315-322. PubMed ID: 29395675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Congenital myasthenic syndromes.
    Hantaï D; Richard P; Koenig J; Eymard B
    Curr Opin Neurol; 2004 Oct; 17(5):539-51. PubMed ID: 15367858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The congenital myasthenic syndrome mutation RAPSN N88K derives from an ancient Indo-European founder.
    Müller JS; Abicht A; Burke G; Cossins J; Richard P; Baumeister SK; Stucka R; Eymard B; Hantaï D; Beeson D; Lochmüller H
    J Med Genet; 2004 Aug; 41(8):e104. PubMed ID: 15286164
    [No Abstract]   [Full Text] [Related]  

  • 47. Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic).
    Donger C; Krejci E; Serradell AP; Eymard B; Bon S; Nicole S; Chateau D; Gary F; Fardeau M; Massoulié J; Guicheney P
    Am J Hum Genet; 1998 Oct; 63(4):967-75. PubMed ID: 9758617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Congenital myasthenic syndrome: a brief review.
    Lorenzoni PJ; Scola RH; Kay CS; Werneck LC
    Pediatr Neurol; 2012 Mar; 46(3):141-8. PubMed ID: 22353287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission.
    Müller JS; Mihaylova V; Abicht A; Lochmüller H
    Expert Rev Mol Med; 2007 Aug; 9(22):1-20. PubMed ID: 17686188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viral vector-mediated [corrected] expression of human collagen Q in cultured cells.
    Ito M; Masuda A; Jinno S; Katagiri T; Krejci E; Ohno K
    Chem Biol Interact; 2008 Sep; 175(1-3):346-8. PubMed ID: 18374322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unique presentation of rapidly fluctuating symptoms in a child with congenital myasthenic syndrome due to RAPSN mutation.
    Kumar A; Asghar S; Kavanagh R; Wicklund MP
    Muscle Nerve; 2018 Oct; 58(4):E23-E24. PubMed ID: 30028532
    [No Abstract]   [Full Text] [Related]  

  • 52. Congenital myasthenic syndrome and minicore-like myopathy with DOK7 mutation.
    Lorenzoni PJ; Scola RH; Kay CS; Lochmüller H; Werneck LC
    Muscle Nerve; 2013 Jul; 48(1):151-2. PubMed ID: 23657916
    [No Abstract]   [Full Text] [Related]  

  • 53. Congenital endplate acetylcholinesterase deficiency responsive to ephedrine.
    Bestue-Cardiel M; Sáenz de Cabezón-Alvarez A; Capablo-Liesa JL; López-Pisón J; Peña-Segura JL; Martin-Martinez J; Engel AG
    Neurology; 2005 Jul; 65(1):144-6. PubMed ID: 16009904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction.
    Ito M; Suzuki Y; Okada T; Fukudome T; Yoshimura T; Masuda A; Takeda S; Krejci E; Ohno K
    Mol Ther; 2012 Jul; 20(7):1384-92. PubMed ID: 22371845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Congenital myasthenic syndrome in Turkey: clinical and genetic features in the long-term follow-up of patients.
    Gül Mert G; Özcan N; Hergüner Ö; Altunbaşak Ş; Incecik F; Bişgin A; Ceylaner S
    Acta Neurol Belg; 2021 Apr; 121(2):529-534. PubMed ID: 31773638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
    Tsao CY
    Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transcriptional regulation of acetylcholinesterase-associated collagen ColQ: differential expression in fast and slow twitch muscle fibers is driven by distinct promoters.
    Lee HH; Choi RC; Ting AK; Siow NL; Jiang JX; Massoulié J; Tsim KW
    J Biol Chem; 2004 Jun; 279(26):27098-107. PubMed ID: 15102835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sleuthing molecular targets for neurological diseases at the neuromuscular junction.
    Engel AG; Ohno K; Sine SM
    Nat Rev Neurosci; 2003 May; 4(5):339-52. PubMed ID: 12728262
    [No Abstract]   [Full Text] [Related]  

  • 59. Diagnosis of congenital myasthenic syndrome with mutation of the RAPSN gene after general anaesthesia.
    Gentili A; Ansaloni S; Morello W; Cecini MT; Cordelli DM; Baroncini S
    Eur J Anaesthesiol; 2011 Oct; 28(10):748-9. PubMed ID: 21372719
    [No Abstract]   [Full Text] [Related]  

  • 60. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.
    Engel AG; Shen XM; Selcen D; Sine SM
    Lancet Neurol; 2015 Apr; 14(4):420-34. PubMed ID: 25792100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.